Fidelity Wise Origin Bitcoin Fund amends trust agreement to allow in-kind share transactions
Investing.com - Savara reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Savara announced earnings per share of $-0.0700 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.0680 on revenue of $0.00.
Savara 's are down 53.92% and is trading at $1.1400 , still down 40.31% from its 52 week high of $1.91 set on Monday, July 11, 2022.
Savara follows other major Healthcare sector earnings this month
Savara's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar